ARGS
Argos Therapeutics, Inc.
ARGS
ARGS
Delisted
ARGS was delisted on the 24th of April, 2018.
28 hedge funds and large institutions have $456K invested in Argos Therapeutics, Inc. in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
84% less capital invested
Capital invested by funds: $2.89M → $456K (-$2.44M)
Holders
28
Holding in Top 10
1
Calls
$615K
Puts
–
Top Buyers
| 1 | +$29.2K | |
| 2 | +$9.84K | |
| 3 | +$6.05K | |
| 4 |
SMH
Sanders Morris Harris
Houston,
Texas
|
+$4.32K |
| 5 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$4K |
Top Sellers
| 1 | -$32K | |
| 2 | -$14.9K | |
| 3 | -$8.37K | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$5K |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$3.37K |